Tumorigenesis and Development of the Pituitary and Hypothalamus

OR35-2

The Enhanced Proteasomal Degradation of AIP Mutant Proteins Is a Mechanism for AIP Deficiency in AIP mutation-Associated Pituitary Adenomas
Laura C. Hernández Ramírez, Federico Martucci, Francesco Ferraù, Rhodri M.L. Morgan, Giampaolo Trivellin, Fauzia Begum, Daniel Tilley, Nancy Ramos-Guajardo, Donato Iacovazzo, Chrisostomos Prodromou and Márta Korbonits

OR35-3

Expression of Somatostatin Receptor 2 & 5 and AIP: Useful Tools to Predict Responsiveness to Conventional Somatostatin Analogs and Pasireotide Treatment in Acromegaly
Donato Iacovazzo, Eivind Carlsen, Francesca Lugli, Sabrina Chiloiro, Serena Piacentini, Antonio Bianchi, Antonella Giampietro, Marilda Mormando, Andrew J Clear, Carmelo Anile, Giulio Maira, Libero Lauriola, Guido Rindi, Maurizio Spinello, Márta Korbonits and Laura De Marinis

OR35-4

Genomic and Genetic Analysis of Growth Hormone Pituitary Tumor Subtypes
Katja Kiseljak-Vassiliades, Katherine Gowan, Mei Xu, Taylor S Mills, BK Kleinschmidt-Demasters, Kevin Lillehei, Kenneth Jones and Margaret E Wierman

OR35-6

Mutations in the Wnt/b-Catenin Effector Tcf3/TCF7L1 Are Associated with Septa-Optic Dysplasia in Mouse and Humans
Carles Gaston-Massuet, Mark J McCabe, Valeria Scagliotti, Louise Cheryl Gregory, Sujata Jayakody, Juan Pedro Martinez-Barbera and Mehul Tulsidas Dattani